Agios Pharmaceuticals (AGIO) Current Taxes (2012 - 2025)

Agios Pharmaceuticals (AGIO) posted Current Taxes of $683000.0 for Q1 2025, down 21.58% on a QoQ basis from $871000.0 in Q4 2024.

Agios Pharmaceuticals (AGIO) Current Taxes (2012 - 2025) Analysis & Trends

Agios Pharmaceuticals' Current Taxes history runs 5 years deep, the most recent figure standing at $683000.0 for Q1 2025.

Quarterly Current Taxes changed N/A year-over-year to $683000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $683000.0 (changed N/A YoY) and the FY2024 annual result came in at $871000.0, changed N/A from the prior year.
Current Taxes was $683000.0 for Q1 2025 at Agios Pharmaceuticals, down from $871000.0 in the prior quarter.
Across five years, Current Taxes topped out at $52.7 million in Q3 2024 and bottomed at $683000.0 in Q1 2025.
A 3-year average of $13.8 million and a median of $7.6 million in 2021 frame the typical range for Current Taxes.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Agios Pharmaceuticals	2.13 Bn	2.13 Bn	19.43 Mn	-

Download Data